Competition | Regulation | Litigation
News
22-06-2018
Maverick Advocaten speaks at the Benelux Trademarks Congress
Martijn van de Hel spoke about the developments in the area of trademarks and competition law at the Benelux Trademarks Congress. Read more >
25-05-2018
Interview with Martijn van de Hel about the impact of the Netherlands commercial court on competition procedures
Martijn van de Hel has been interviewed by the international competition news agency Parr about the consequences of the foundation of the Netherlands Commercial Court (NCC). Read more >
01-05-2018
Maverick Advocaten in M&A Community on gun jumping
Diederik Schrijvershof wrote a blog for M&A Community concerning the record fine the European Commission imposed on Altice. Read more >
30-04-2018
Maverick Advocaten in Zorgvisie Magazine regarding healthcare procurement process
Diederik Schrijvershof explains in Zorgvisie Magazine what healthcare insurers must do in order to comply with the covenant to establish an independent healthcare contracting dispute resolution authority in 2018. Read more >
16-04-2018
Maverick Advocaten higher in ranking Legal500: ‘fast, well-connected and very alert’
Legal500 praises Maverick’s excellent position in the field of competition law. Read more >
12-03-2018
''Flourishing competition boutique'' again at the top of Dutch law firms
Chambers has again ranked Maverick Advocaten in the list of best Dutch law firms in the field of competition law. Read more >
09-03-2018
Maverick Advocaten in FD about ACM’s oversight efforts regarding (expensive) prescription drugs
Diederik Schrijvershof provided his opinion in an article in Het Financieele Dagblad about the heightened attention of ACM for producers of prescription drugs and abuse of dominance. Read more >
06-03-2018
Maverick Advocaten lectures at University Leiden
Maverick Advocaten presented a lecture on "Abuse of Dominance" at the University of Leiden Read more >
14-02-2018
Maverick Advocaten speaks about ACM’s and the European Commission’s oversight efforts regarding expensive prescription drugs
Diederik Schrijvershof reacts to a key priority of ACM in 2018-2019: prices of prescription drugs. Read more >
13-02-2018
Maverick’s opinion on ACM supervision in Het Financieele Dagblad
Martijn van de Hel and Diederik Schrijvershof in FD on ACM supervision. Read more >